Direct acquisition; Oligonucleotides for PCR (primers and probes)
Ausschreibungsinformationen
TED EUVADSØ, Norway
- Art
- 25
- Verfahren
- neg-wo-call
- Referenznummer
- 541818-2025
- CPV
- 38000000
Helse Bergen HF and with options for Helse Stavanger HF and Helse Førde HF have the intention to enter into framework agreements with two vendors, TIB Molbiol Syntheselabor GmbH and Life Technologies AS for Oligonucleoti…